Skip to main content

Closed

ADXN: Addex Therapeutics Ltd Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-92.6% / yr

Operating margin-2999.7%

ROIC-74.4%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage-145.7×

Current ratio0.97×

Addex Therapeutics Ltd

ADXNNASDAQ Capital Market·USD·Closed

Addex Therapeutics Ltd

ADXNNASDAQ·USD·Closed

$5.20

−7.06%

$5.20

−$0.39 (7.06%)

52W Range

2thpctl

Volume

1.52×avg

Mkt Cap

3.75MUSD

P/E

-0.7TTM

Div Yield

–ann

52W Range

2thpctl

Volume

1.52×avg

Market Cap

3.75MUSD

P/E Ratio

-0.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings